Research and Markets: Global Bipolar Disorders Drug Pipeline Capsule - 2012 Update

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/vb5wjt/global_bipolar) has announced the addition of the "Global Bipolar Disorders Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Bipolar Disorders Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Bipolar Disorders market. It covers active Bipolar Disorders pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Topics Covered:

1. Bipolar Disorders - Disease Overview

2. Bipolar Disorders Pipeline Overview

3. Bipolar Disorders Phase 3 Clinical Trial Pipeline Insights

4. Bipolar Disorders Phase 2 Clinical Trial Pipeline Insights

5. Bipolar Disorders Phase 1 Clinical Trial Pipeline Insights

6. Bipolar Disorders Preclinical Research Pipeline Insights

7. Bipolar Disorders Discovery Stage Pipeline Insights

8. Bipolar Disorders Drug Development Activities - Geographic Landscape

8.1. Bipolar Disorders R&D Activities in North America

8.2. Bipolar Disorders R&D Activities in Europe

9. Bipolar Disorders Pipeline - Licensing Activities

Table 1. Bipolar Disorders Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Bipolar Disorders Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Bipolar Disorders Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Bipolar Disorders Pipeline Molecules - Preclinical Research

Table 5. Bipolar Disorders Pipeline Molecules - Drug Discovery

Table 6. Bipolar Disorders R&D Activities by Geography

Table 7. Bipolar Disorders Pipeline Molecules - North America

Table 8. Bipolar Disorders Pipeline Molecules - Europe

Table 9. Bipolar Disorders Pipeline - Licensing Activities

Figure 1. Bipolar Disorders Pipeline Molecules by R&D Stage

Figure 2. Bipolar Disorders R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/vb5wjt/global_bipolar

Source: http://news.yahoo.com/research-markets-global-bipolar-disorders-144400841.html

ryan leaf ryan leaf luke kuechly brad miller chandler jones peyton hillis fletcher cox